| Literature DB >> 33039972 |
Léa Pillette1, Fabien Lotte2, Bernard N'Kaoua3, Pierre-Alain Joseph4, Camille Jeunet5, Bertrand Glize6.
Abstract
The neuronal loss resulting from stroke forces 80% of the patients to undergo motor rehabilitation, for which Brain-Computer Interfaces (BCIs) and NeuroFeedback (NF) can be used. During the rehabilitation, when patients attempt or imagine performing a movement, BCIs/NF provide them with a synchronized sensory (e.g., tactile) feedback based on their sensorimotor-related brain activity that aims at fostering brain plasticity and motor recovery. The co-activation of ascending (i.e., somatosensory) and descending (i.e., motor) networks indeed enables significant functional motor improvement, together with significant sensorimotor-related neurophysiological changes. Somatosensory abilities are essential for patients to perceive the feedback provided by the BCI system. Thus, somatosensory impairments may significantly alter the efficiency of BCI-based motor rehabilitation. In order to precisely understand and assess the impact of somatosensory impairments, we first review the literature on post-stroke BCI-based motor rehabilitation (14 randomized clinical trials). We show that despite the central role that somatosensory abilities play on BCI-based motor rehabilitation post-stroke, the latter are rarely reported and used as inclusion/exclusion criteria in the literature on the matter. We then argue that somatosensory abilities have repeatedly been shown to influence the motor rehabilitation outcome, in general. This stresses the importance of also considering them and reporting them in the literature in BCI-based rehabilitation after stroke, especially since half of post-stroke patients suffer from somatosensory impairments. We argue that somatosensory abilities should systematically be assessed, controlled and reported if we want to precisely assess the influence they have on BCI efficiency. Not doing so could result in the misinterpretation of reported results, while doing so could improve (1) our understanding of the mechanisms underlying motor recovery (2) our ability to adapt the therapy to the patients' impairments and (3) our comprehension of the between-subject and between-study variability of therapeutic outcomes mentioned in the literature.Entities:
Keywords: Brain-computer interfaces; Motor recovery; Neurofeedback; Somatosensory impairments; Stroke rehabilitation
Mesh:
Year: 2020 PMID: 33039972 PMCID: PMC7551360 DOI: 10.1016/j.nicl.2020.102417
Source DB: PubMed Journal: Neuroimage Clin ISSN: 2213-1582 Impact factor: 4.881
Characteristics of the studies selected for this review. Main elements of the studies (columns 1 to 8), then mechanisms quoted by the authors to explain their results (column 9) and finally our analysis of the potential factors (intrinsic to the patients, e.g., somatosensory loss, or extrinsic to the patients, e.g., design issues) that could arise from the inclusion/exclusion criteria presented in Table 2 (column 10) are introduced. During the studies patients were either asked to perform motor-imagery (MI) or motor-attempt (MA) tasks. If they were reported in the article for both the experimental (exp) and control (contr) groups the number of patients included, chronicity and motor impairment of are reported in such order and separated by a slash. If not the average is provided. Chronicity is defined by the time between the stroke and the inclusion in the study such as: Acute= <1 month, Subacute= <3 months and Chronic= >3 months. Mean and standard deviation of time from stroke for each group distinctly or globally are provided either in days or months. When provided in the article minimal and maximal values are also reported, i.e., (min–max). Mean and standard deviation of motor impairment at inclusion is provided using the Fugl-Meyer Assessment of Upper Extremity (FMA-UE), Jebsen Hand Function Test (JHFT), Action Research Arm Test (ARAT) and Brunnstrom recovery stage. Indication regarding the motor capacity of the subjects are provided depending on the FMA-UE scores, i.e., no: 0–22, poor: 23–31, limited: 32–47, notable: 48–52, full:53–66, or on the ARAT scores, i.e., no: 0–10, poor: 11–21, limited: 22–42, notable: 43–54, full:55–57. Following is a list of the abbreviations used in the table and their signification: Classification Accuracy (CA), Blood Oxygen Level Dependent effect (BOLD), Diffusion Tensor Imaging (DTI), ElectroEncephaloGraphy (EEG), Electromyogram (EMG), European Stroke Scale (ESS), Event Related Desynchronization (ERD), functional Magnetic Resonance Imaging (fMRI), Goal Attainment Scale (GAS), Hand Grip Strength (HGS), Lateralization Index (LI), Medical Research Council (MRC), Modified Ashworth Scale (MAS), Motor Activity Log (MAL), Motor Evoked Potential (MEP), NASA Task Load Index (NASA-TLX), National Institute of Health Stroke Scale (NIHSS), Near InfraRed Spectroscopy (NIRS), Nine Hole Peg test (9-HPT), Power Spectral Density (PSD), Resting State Connectivity (RSC), revised Brain Symmetry Index (rBSI), SensoriMotor Cortex (SMC), Stroke Impact Scale (SIS), Transcranial Magnetic Stimulation (TMS).
| ( | Compares the effect of MI-BCI with robotic feedback to standard robotic rehabilitation on functional improvement | Blindness not described, 18 (8/10), Subacute and chronic (Days, 385,5 ± 293,5 (57–1053)) | No capacity to full capacity (FMA-UE, 29,7 ± 17,7 (4–61)) | MI-BCI (EEG) to drive robotic orthosis to move the shoulder and elbow of the impaired arm with gamified visual feedback | Standard robotic rehabilitation | FMA-UE | Significant functional improvement post-rehabilitation and at the 2-months follow-up when groups are combined. Significant greater improvement in MI-BCI group for the 2 months follow-up after removal of the non-responders in both groups and correction for age and gender. | No hypothesis regarding underlying neurophysiological mechanisms. | Non-responders might have been due to abnormal abilities (visual, somatosensory, etc.) but not described. No prior assessment of somatosensory-related abilities for inclusion/exclusion criteria. Possible randomization bias. |
| ( | Compares the effect of MI-BCI with robotic feedback to standard robotic rehabilitation on functional improvement | Blindness not described, 25 (11/14), Subacute and chronic (Days, 383 ± 291 (71–831)/ 250 ± 184 (37–668)) | No capacity to limited capacity (FMA-UE, 26,3 ± 10,3 (14–47)/ 26,6 ± 18,9 (4–57)) | MI-BCI (EEG) to drive robotic orthosis to move the shoulder and elbow of the impaired arm with gamified visual feedback | Standard robotic rehabilitation | FMA-UE | Significant functional improvement in both groups post-rehabilitation and at the 2-months follow-up. Slightly less functional improvement in the MI-BCI group but not significant. | “Ipsilesional motor cortex activation from motor imagery is effective in restoring upper extremities motor function in stroke.” | No prior assessment of somatosensory-related abilities for inclusion/exclusion criteria. Possible randomization bias. |
| ( | Compares the effect of MI-BCI with robotic feedback to standard robotic rehabilitation and standard motor rehabilitation on functional improvement | Blinded assessment, 21 (6/8/7), Chronic (Days, 285,7 ± 64/ 398,2 ± 150,9/ 455,4 ± 109,6 (191–651)) | No capacity to notable capacity (FMA-UE, 33 ± 16,2/ 25,5 ± 11,5/ 23,4 ± 14,5 (10–50)) | MI-BCI (EEG) to drive robotic orthosis for fingers extension and wrist rotation with visual feedback | Standard robotic rehabilitation/ Standard Arm therapy | FMA-UE | Significant functional improvements in all groups 6 weeks post-rehabilitation still significant at 12 and 24 weeks follow-up for the MI-BCI and standard robotic groups. Significantly greater functional improvement for the MI-BCI group compared to the standard therapy group at 3, 12 and 14 weeks follow-ups. | “[…] performance of MI in the [experimental] group […] facilitated neuroplasticity” | No prior assessment of somatosensory-related abilities for inclusion/exclusion criteria except pain and spatial neglect. Possible randomization bias. |
| ( | Compares the effect of MI-BCI with robotic feedback to standard robotic rehabilitation on functional and physiological improvement | Blinded assessment, 25 (11/14), Chronic (Days, 383 ± 290,8/ 234,7 ± 183,8) | No capacity to limited capacity (FMA-UE, 26,3 ± 10,3/ 26,5 ± 18,2 (4–40)) | MI-BCI (EEG) to drive robotic orthosis to move the shoulder and elbow of the impaired arm with gamified visual feedback | Standard robotic rehabilitation | FMA-UE, EEG (rBSI) | Significant functional improvement for both groups post-rehabilitation. Slightly less functional improvement in the BCI group close to significant post-training that could be caused by reduced arm exercise repetitions in BCI group. Negative correlation of rBSI over the sessions and functional improvement for the experimental group. Higher asymmetry in spectral power between the 2 cerebral hemispheres associated with less motor recovery in the BCI group. | “[…] possible role for BCI in long-term cortical plasticity.” | Non-responders might have been due to abnormal somatosensory abilities but not described. No prior assessment of somatosensory-related abilities for inclusion/exclusion criteria except pain and spatial neglect. Possible randomization bias. |
| ( | Compares the effect of MA-BCI with FES feedback to MA-BCI with sham FES feedback on functional and physiological improvement | Double blinded, 27 (14/13), Chronic (Months, 39,79 ± 45,9 (10–176)/ 33,46 ± 30,51 (11–121)) | No capacity to limited capacity (FMA-UE, 21,6 ± 10,8 (7–37)/ 19,9 ± 11,2 (4–40)) | MA-BCI (EEG) to trigger FES for fingers and wrist extension | Sham (random FES feedback) | FMA-UE, MRC, MAS, ESS | Significant functional recovery (FMA-UE, MRC) sustained at the 6 to 12 months follow-up correlated with significant increase in functional connectivity between motor areas in the affected hemisphere in favor of the BCI group | “BCI-FES therapy can drive significant functional recovery and purposeful plasticity thanks to contingent activation of body natural efferent and afferent pathways” “through” “somatosensory input, in the form of peripheral nerve stimulation” | No prior assessment of somatosensory-related abilities for inclusion/exclusion criteria except spatial neglect. Possible randomization bias. |
| ( | Compares the effect of MI-BCI with robotic feedback to sham robotic feedback on functional improvement | Blinded assessment, 74 (55/19), Subacute and chronic (Median Months, 8 [4–13]/ 8 [1–13]) | No capacity to limited capacity (Median FMA-UE, 24 [12–14]/ 12 [11–49]) | MI-BCI (EEG) to drive robotic orthosis for fingers extension and simple visual feedback | Sham without MI but with EEG (random robotic feedback) | FMA-UE, ARAT, MAS | Significant functional recovery (ARAT, FMA-UE) for both groups. More patients from the experimental group than the control group reached the MCID threashold (ARAT, FMA-UE). Correlation between CA and rehabilitation outcome (ARAT, FMA-UE). | “The kinesthetic imagination of both affected and unaffected limbs and even transition to the motor relaxation are related to motor functions and generally influence the mechanisms of neuroplasticity resulting in motor recovery.” | Worst motor impairments in the control group which could be due to greater somatosensory impairments. No prior assessment of somatosensory-related abilities for inclusion/exclusion criteria. Possible randomization bias. |
| ( | Compares the effect of MI-BCI with FES feedback to standard FES therapy on functional and physiological improvement | Blindness not described, 14 (7/7), Subacute and chronic (Months, 2,21 ± 1,8 (1–6)/ 2,79 ± 2 (1–6)) | No capacity to poor capacity (FMA-UE, 13,57 ± 4,72 (9–22)/ 11,71 ± 2,63 (9–16)) | MI-BCI (EEG) to trigger FES for wrist extension with gamified visual and auditory feedback | Standard FES therapy | FMA-UE, ARAT, EEG (ERD) | Significant functional improvement for both groups (ARAT, FMA-UE). Significant functional improvement (ARAT) of the experimental group compared to the control group at the 6 week follow-up. Significantly stronger ERD of the affected sensorimotor cortex for the experimental group post-training but not significantly different than the control group. Significant negative correlation of the ERD value and functional improvement (ARAT, FMA-UE). CA of the experimental group significantly improved and was significantly higher than the one from the control group. | “BCI training [using MI task and FES feedback] may enhance the activation of the affected SMC to prime the motor functional reorganization” | No prior assessment of somatosensory-related abilities for inclusion/exclusion criteria. Possible randomization bias. |
| ( | Compares the effect of MI-BCI with visual feedback to MI-BCI with sham visual feedback on functional and physiological improvement | Double blinded, 20 (10/10), Chronic (Days, 146,6 ± 36,2 (94–190)/ 123,4 ± 38,27 (89–194)) | No capacity to notable capacity (FMA-UE, 22,5 ± 14,14 (9–50)/ 24 ± 13,8 (4–50)) | MI-BCI (NIRS) to provide visual feedback | Sham (random visual feedback) | FMA-UE, ARAT, MAL, NIRS (BOLD) | Significant functional improvement for the experimental group (FMA-UE hand/finger subscale). Greater functional improvement for the experimental group associated with significantly greater motor imagery-related cortical activation (ipsilesional premotor area). | “[…] modulation of the excitability in the premotor area and related networks augments the functional recovery.” | No description of the precise sensory assessment limiting the reproductibility of the study. |
| ( | Compares the effect of MI to MI-BCI with realistic visual feedback on functional and physiological improvement | Double blinded, 28 (14/14), Subacute, (Months, 2,7 ± 1,7/ 2,5 ± 1,2) | ~No to limited capacity (FMA-UE, 23,4 ± 17,3/ 24,2 ± 18,2) | MI-BCI (EEG) to provide realistic visual feedback (finger extension of a virtual hand) | Standard MI therapy | FMA-UE, MRC, NIHSS, MAS, NASA-TLX, TMS (MEP), EEG (RSC, PSD) | Significant functional improvement for both groups (FMA-UE, MRC, NIHSS). Significantly higher functional improvement for the experimental group (FMA-UE, MRC, NIHSS) correlated with intrahemispheric connectivity increase at rest in the affected hemisphere (FMA-UE). Probability of reaching the MCID for FMA-UE significantly higher for the experimental group. Significantly higher working memory involvment for the BCI group (NASA-TLX). Significantly more robost desynchronisation for the experimental group than for the control group post-training. | “[…] it is plausible that the BCI promoted the activity of sensorimotor areas (the ipsilesional parietal area and mesial premotor and supplementary motor areas) other than the primary motor cortex that are stimulated during MI implying that the better clinical outcomes in the BCI group were mediated by compensatory changes rather than the restoration of primary motor cortex activity.” | No prior assessment of somatosensory-related abilities for inclusion/exclusion criteria except spatial neglect. Possible randomization bias. |
| ( | Compares the short term effect of MA-BCI with robotic feedback to MA-BCI with robotic sham feedback on functional and physiological improvement | Double blinded, 32 (16/16), Chronic (Months, 66 ± 45/ 71 ± 72) | ~No to poor capacity (cFMA-UE, 11,15 ± 6,92/ 13,28 ± 10,71) | MA-BCI (EEG) to drive robotic orthosis to move the upper limb forward and for finger extension | Sham (random robotic feedback) | FMA-UE, GAS, MAL, Ashworth scale, fMRI (LI), EMG | Significant functional improvement (FMA-UE, EMG) in the BCI group not present for the control group correlated with LI for patients with subcortical lesions (FMA-UE). Significant functional improvement (GAS, MAL) for both groups. Significant physiological improvement (LI) for the experimental group not found for the control group. | “BMI training, involving proprioceptive positive feedback and reward that is time-contingent upon control of ipsilesional sensorimotor brain oscillations, may prime and thus improve the beneficial effects of physiotherapy on motor function.” | No prior assessment of somatosensory-related abilities for inclusion/exclusion criteria except pain. Possible randomization bias. |
| ( | Compares the effect of occupational therapy with MI-BCI using gamified feedback or with EMG biofeedback or alone on functional and physiological improvement | Blinded assessment and statistics, 30 (10/10/10), Chronic (Months, 8,5 ± 6/ 8,7 ± 10,8/ 8 ± 8,8) | N.A. (JHFT, 169 ± 66/ 167 ± 83/ 175 ± 78) | Occupational therapy and MI-BCI (EEG) to control a game (visual and auditory feedback) | Occupational therapy and EMG biofeedback, Occupational therapy alone | JHFT, EEG (PSD) | Similar funtional improvement in all the groups (JHFT). Significant increase of the PSD of the SMR band in the BCI group. Significant increase of mean and maximum contraction values of electrical activities of the paretic hand in the biofeedback group. Improved satisfaction for the biofeedback groups. | MI enables to increase or decrease SMR which was shown to be correlated with motor improvement post-stroke. | No description of the precise sensory assessment limiting the reproductibility of the study. |
| ( | Compares the effect of MI-BCI with robotic feedback to standard robotic rehabilitation on physiological change | Blindness not described, 9 (6/3), Subacute and chronic (Months, 11,67 ± 13,51 (3,9–8,8)/ 6,8 ± 6,5 (3,2–35,1)) | Moderate to severe impairments (FMA-UE, 17,67 ± 16,28 (4–23)/ 14,67 ± 9,71 (4–39)) | MI-BCI (EEG) to drive robotic orthosis to move the shoulder and elbow of the impaired arm with gamified visual feedback | Standard robotic rehabilitation | fMRI (resting state), FMA-UE | Difference in resting state fMRI pre-post training are predictor of functional improvement (FMA-UE). | “MI-BCI training presumably strengthens the reassociation of neural representations of the paretic limb and the experienced afference, which could lead to better recovery.” | No prior assessment of somatosensory-related abilities for inclusion/exclusion criteria. Possible randomization bias. |
| ( | Compares the effect of MI-BCI with robotic feedback to MI-BCI with sham robotic feedback on functional and physiological improvement | Crossover study, Blindness not described, 9, Subacute and chronic (Days, 104 ± 24) | N.A., Brunnstrom recovery stage from II to IV | MI-BCI (EEG) to drive robotic orthosis for finger extension and congruent visual feedback | Sham (random robotic feedback) | EEG (ERD), MAS, FMA-UE | Strong tendendy of increase of the ERD strength on the affected side and significant improvement of the spasticity (MAS) after BCI training none of which is observed in the control condition. Significant improvement of the spasticity after the BCI training which is not observed in the control condition. | “[…] promotion of remaining motor neurons on the affected hemisphere and the suppression of the hyperactivity of the unaffected hemisphere […] leading to better prognosis.” | No prior assessment of somatosensory-related abilities for inclusion/exclusion criteria reported. Possible randomization bias. |
| ( | Compares the effect of MA-BCI with multimodal feedback (Visual, FES and tongue stimulation) to customary care on functional and physiological improvement | Crossover study, Blindness not described, 19 (17/10), Subacute and chronic (Months, 34,53 ± 44,14 (2–168)) | No capacity to full capacity (ARAT, 30,06 ± 25,37 (0–57)/ 32,1 ± 24,96 (0–57)) | MA-BCI (EEG) to trigger visual feedback, FES for finger extension and tongue stimulation | Customary care | ARAT, SIS, 9-HPT, DTI | No significant neurophysiological difference between the control and experimental group (ARAT, SIS, 9-HPT, DTI). Fractional anisotropy values are significantly correlated to functional improvement (ARAT, SIS, 9-HPT). | N.A. | Non-responders might have been due to abnormal somatosensory abilities but not described. No prior assessment of somatosensory-related abilities for inclusion/exclusion criteria. Possible randomization bias. |
Inclusion and exclusion criteria related to somatosensory impairments of the studies selected for this review. When stated by the authors the test or questionnaire associated with the criteria are stated in parentheses after the later. Following is a list of the abbreviations used in the table and their signification: Abbreviated Mental Test (AMT), Fugl-Meyer Assessment of Upper Extremity (FMA-UE), Intelligence quotient (IQ), Medical Research Council (MRC), Mini-Mental State Examination (MMSE), Modified Ashworth Scale (MAS), Montreal Cognitive Assessment (MoCA), Upper Extremity (UE), Visual Analogue Scale (VAS).
| ( | |||||||||
| ( | |||||||||
| ( | Yes | >4 months | No capacity to notable capacity (FMA-UE | No severe visual impairement | No pain (VAS | Able to understand simple instructions, No inattention, No severe depression, No psychiatric disorder | No severe aphasia | No hemispatial neglect | |
| ( | Yes | >3 months | No capacity to limited capacity (FMA-UE | No severe visual impairement | No pain (VAS | Able to understand simple instructions (AMT > 6), No cognitive deficits, No severe depression | No severe aphasia | No hemispatial neglect | |
| ( | No capacity to limited capacity (FMA-UE | Good or corrected eyesight | Able to understand simple instructions, No cognitive deficits preventing to perform the rehabilitation task (Raven’s Test), No patients under heavy medication affecting the central nervous system (including vigilance) | No hemispatial neglect | |||||
| ( | Yes | Hand paresis (MRC, mild to plegia), No spasticity (MAS < 4) | No severe vision impairment | No severe cognitive impairment (MoCA > 10) | No sensory aphasia, No severe motor aphasia | ||||
| ( | Yes (with KVIQ assessment) | 1 to 6 months | Affected UE (Brunnstrom period level between I and III) | No cognitive impairment (MMSE > 27), Able to perform MI tasks evidenced by KVIQ, Able to understand the experimental commands | No speech disorders | ||||
| ( | Yes (with KVIQ assessment) | Motor hemiparesis (FMA-UE | No hemianopia | No sensory loss | No cognitive impairment (MMSE | No moderate to severe aphasia | No spatial neglect | ||
| ( | Yes | 6 weeks to 6 months | Hemiplegia or hemiparesis, No spasticity (MAS < 4), No apraxia | No cognitive impairment (MMSE > 24) | No severe aphasia | No severe hemispatial neglect | |||
| ( | >10 months | Paresis of one hand, No active finger extension, No cerebellar lesion or bilateral motor deficit | No severe pain | Able to follow and understand instruction, No psychiatric or neurological condition other than stroke, No depression, IQ above 80 | No severe aphasia | ||||
| Rayegani et al., 2013 ( | Yes | 3 to 12 months | Good trunk balance, Good motor recovery (stage 4 to 5 of Brunnstrom’s stage of motor recovery), Partial ability to grasp and release | No sensory impairment in the upper limbs | No cognitive disorders making communication difficult | ||||
| Varkuti et al., 2013 ( | No capacity to limited capacity (FMA | ||||||||
| ( | Yes | ||||||||
| ( | Persistent UE motor impairment | No other known neurologic, psychiatric or developmental disabilities | |||||||
Fig. 1Schematic representation of BCI-based motor rehabilitation post-stroke taking into account the somatosensory abilities. The elements that might be impacted by the somatosensory impairments of the patients are colored in green. The photo of the person receiving sensory feedback during BCI-based motor rehabilitation is provided courtesy of ©EPFL/Alain Herzog.
Summary of the recommendations and ideas for future research for each of the main elements of BCI-based motor rehabilitation post-stroke presented in Fig. 1.
| Assess somatosensory abilities using dedicated standardized tests and if possible physiological measures | Assess the influence of BCI-based motor therapy on somatosensory abilities and vice versa | |
| Record somatosensory-related activity | ||
| Study the contribution of somatosensory-related activity on machine learning BCI models | ||
| Take into account the somatosensory abilities when assessing the influence of a modality of feedback | Adapt the feedback, e.g., its modality, to the somatosensory abilities |